Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect

Yasushi ObaseDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapanCorrespondence[email protected]

, MD,

Masaki IkedaDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Koji KuroseDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Masaaki AbeDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Hiroki ShimizuDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Yoshihiro OhueDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Keiji MouriDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Shigeki KatohDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD,

Yoshihiro KobashiDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

, MD &

Mikio OkaDepartment of Respiratory Medicine, Kawasaki Medical School Matsushima, KurashikiJapan

Articles from other publishers (9)